New 12-month FORWARD PAD outcomes reinforce the performance of #ShockwaveJavelin# as a safe and effective tool for modifying calcium and crossing challenging lesions in complex PAD. ⚡ At one year, treatment with Javelin resulted in fCD-TLR of 85%, despite being used in a cohort with advanced PAD (42% CTOs and 84% with severe calcification). Read the 12-month outcomes in @MyJSCAI: Thank you to all study investigators for their contributions and commitment to improving outcomes for patients with PAD: Drs. Andrew Holden, Daniel Clair (@scarolinavasc), JD Corl (@JDCorlMD), Sameh Sayfo (@Samsayfo), Bibombe P. Mwipatayi, Manar Khashram (@ManarKhashram), Nicolas Shammas (@nicolas_shammas), Anderson Mehrle, Anvar Babaev, Peter Soukas (@PeterSoukas), Richard Pin, and Nick West US Rx only. Safety Info: Product availability may vary by country.